COVID-19 PANDEMİSİNDE KANSER HASTALARINDA TEDAVİ VE BAKIM YÖNETİMİ: SİSTEMATİK DERLEME

Abstract

Amaç: Bu çalışmada COVID-19 pandemi sürecinde kanser tedavisi ve bakım yönetimi” konusu ile ilgili yayınlanmış çalışmaların sistematik olarak değerlendirilmesi amaçlanmıştır. Yöntem: Derleme için 1-30 Nisan 2020 tarihinde Covid-19, kanser ve kemoterapi anahtar kelimeleri kullanılarak PubMed, Medline, Google Akademik ve Cochrane veri tabanlarından makale taraması yapıldı. 366 adet makaleye ulaşıldı. Çalışmanın konusu ile ilgili araştırma sayısı 50 idi. Dahil edilme kriterlerine uyan 7 makale değerlendirmeye alındı. Verilerin elde edilmesinde makalelerin raporlama özelliklerini belirlemek için geliştirilmiş, 27 maddelik PRISMA (Preferred Reporting Items for Systematic Reviews) Bildirgesi Formu kullanıldı. Bulgular: İncelenen araştırmalarda kanser tanılı hastalar Covid -19 pandemisinde genel popülasyona göre daha riskli olarak kabul edilmektedir. Özellikle ek hastalıklara sahip ve ileri yaştaki kanser hastalarında risk daha da artmakta ve Covid-19 enfeksiyonu bağlı pnömoni daha ciddi seyretmektedir. Pandemi döneminde riski arttıran diğer değişkenlerden kanser türü evresi ve antikanser tedavi alma durumları konusunda net veriler bulunmamakla birlikte bu değişkenlerin de riski arttırdığı düşünülmektedir. Sonuç: Covid-19 pandemisinde kanser tanılı hastalar, riskli grup kabul edilmekle birlikte enfeksiyon geliştiğinde daha ciddi olaylar geliştirebilme ihtimalinin yüksek olması nedeniyle daha ayrıntılı ele alınması gereken gruptur. Bu nedenle kanser tanılı hastaların pandemi döneminde korunması, bulaş risklerinin azaltılması ve tedavi devamlılığının sağlanabilmesi açısından yeni politikaların oluşturulmasına ihtiyaç vardır.

Keywords

• Koronavirüs
• kanser
• hemşire
• kemoterapi

TREATMENT AND CARE MANAGEMENT IN CANCER PATIENTS DURING THE COVID-19 PANDEMIC: A SYSTEMATIC REVIEW

Abstract

Aim: In this study, it is aimed to systematically evaluate the published studies on the subject of "cancer treatment and care management during the COVID-19 pandemic process. Methods: For review, articles accessed using PubMed, Medline, Google Scholar and Cochrane databases in April 2020 were scanned. The screening was done using combinations of the keyword cancer, chemotherapy, Covid-19. 366 articles were found as a result of the search. The number of studies on the subject of the study was 50. 7 articles from the scanned publications meeting the study criteria were evaluated. The 27-item Preferred Reporting Items for Systematic Reviews Declaration Form, developed to determine the reporting characteristics of the articles, was used to obtain the data. Results: In the studies examined, patients diagnosed with cancer are considered to be more risky in the Covid -19 pandemic compared to the general population. Especially in advanced cancer patients with additional diseases, the risk increases even more and pneumonia due to Covid-19 infection has a more serious. Although there are no clear data on cancer type stage and anticancer treatment among other variables that increase the risk during the pandemic period, these variables are also thought to increase the risk. Conclusion: Although cancer patients are considered a risky group in the Covid-19 pandemic, they should be considered in more detail because the disease progresses more seriously. For this reason, new policies are needed to protect oncology patients during the pandemic period, to reduce the risk of transmission and to ensure the continuity of treatment.

Keywords

• Cancer
• chemotherapy
• nurse
• coronavirus

References

1. Lui K, Chen Y, Lin R, Han Y. Clinical Features Of COVID-19 in Elderly Patients: A Comparison With Young and Middle-aged Patients. Journal of Infection. 2020;15,30. doi.org/10.1016/j.jinf.2020.03.005
2. Buruk K, Özlü T. Yeni Koronavirüs: SARS-CoV-2. Mucosa.2020;3:1-4. doi:10.33204/mucosa706906
3. Wang L, Wang Y, Ye D, Lui Q. A Review of 2019 Novel COVİD-19 Based on Current Evidence, International Journal of Antimicrobial Agents. 2020. doi.org/10.1016/j.ijentimicag.2020.105948
4. Rodriguez- Morales AJ, Cardona-Ospira JA, Gutierrez-Ocampo E, Villamizar-Pena R, Hulguin- Rivera Y, Escalero-Antezara JP, …Sah R. Clinical Laboratory and Imaging Features Of COVID-19: A Systematic Review and Meta Analysis. Travel Medicine and Infectious Disease. 2020. doi.org/10.1016/j.tmaid.2020.101623
5. Shanker A, Saini D, Roy S. Cancer Care Delivery Challenges Amidst Coronavirus Disease-19 Outbreak: Spesific Precautions for Cancer Patients and Canser Care Providers to Prevent Spread. Asian Pasific Journal of Cancer Prevention.2020;21;569-573. doi:10.31557/ap.jcp.2020.21.3.569
6. Remuzzi A, Remuzzi G. Covid-19 and Italy: What Next? Lanset. 2020;395:1225-1228. https://doi.org/10.1016/S0140-6736(20)
7. Ganatra S, Hammond SP, Nohria A. The Novel Coronavirus Disease COVID 19: Threat for Patient With Cardiovasculer Disease and Cancer. JACC Cardiooncology. 2020. doi.org/10.1016/j.jaccao2020.03.001
8. Yang G, Zhang H, Yang Y. Challenges and Countermeasures of Integrative Cancer Therapy in The Epidemic of COVID-19. Integrative Cancer Theraphy.2020;19:1-2. doi:10.11.77./1534735420972811

9. Al-Shamsi H, Alhazanı O, Alhuraıjı W, Coomes EA, Chemaly RF, Almuhanna M, …Grothey A. A Practical Approach to The Management of Cancer Patients During The Novel Coronavirus Disease 2019 Pandemic: An International Collobrative Group. The Oncologist. 2020;25,1-10. doi.org/10.1634/theoncologist.2020-0213
10. Cannizaro R, Puglisi F. Covid-19 and Cancer Patients Choosing Wisely is The Key. Digestive and Liver Disease Journal. 2020. doi.org/10.1016/j.dld.2020.03.30
11. Moher D, Liberati A, Tetzlaff J, Altman DG, & the PRISMA Group. Reprint—preferred reporting items for systematic reviews and metaanalyses: The PRISMA Statement. Physical Therapy. 2009;89(9), 873-880.
12. Zhang L, Zhu F, Xie L, Wang C, Wang L, Chen R, …Zhou M. Clinical Characteristics of COVİD-19 Infected Cancer Patients: A Retrospective Case Study in Three Hospitals Within Wuhan, China. 2020.doi.org/10.1016/j.annonc.2020.03.296
13. Ma J, Yin J, Qion Y, Wu Y. Clinical Characteristic and Prognosis in Cancer Patients With COVİD-19: A Single Center’s Retrospective Study. Journal of Infection. 2020;9:45. doi.org/10.1016/j.inf2020.04.006
14. Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 Transmission in Patients With Cancer at A Tertiary Care Hospital in Wuhan China, Jama Oncology. 2020. doi.org/10.1101/jamaoncol 2020.0980.
15. Desai A, Sachdeva S, Parekin T, Desai R. Covid-19 and Cancer: Lessons From Pooled Meta-Analysis. Ascopubs. 2020. doi.org/10.1200/GO.20.00097
16. Feng Z, Li Q, Zhang Y, Wu Z, Dang X, Ma H, … McGoogan JM. The Epidemiological Characteristic of an Outbreak of 2019 Novel Coronavirus Diseases, CCDC Weekly. 2020;2(8);113-122.
17. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chang M, Lee M. Characteristic and Outcomes of 21 Critically Ill Patients With Covid-19 in Washington State. Jama Oncology. 2020. doi.10.1001/jama 2020.4326